Medicine Man Technologies Inc (SHWZ)

[Future2016]

“Our objective is to more than double our pro forma revenue in the next 12 months.”

“Turning now to our 2021 outlook. We are projecting total annual revenue of approximately $105 million to $125 million and adjusted EBITDA, which is a non-GAAP measure, of approximately $28 million to $36 million. These ranges exclude any unannounced acquisitions that we may complete this year...

We are cautiously optimistic about 2021. Based on results to date, integration of the Star Buds acquisitions is going well. As with Mesa Organics and Purplebee's, we believe that the team will create greater than expected synergies. We also feel there are a number of external challenges that may influence our results, such as COVID-19 government stimulus and legislation. Finally, as Justin indicated, we are determined to double our pro forma revenue over the next 12 months through accretive acquisitions and internal growth.”

“Nancy has already provided our outlook for 2021 with respect to our current operations. But I think it is important to reiterate that our goal is to double pro forma revenue over the next 12 months through accretive acquisitions and internal growth.”

“I am energized and confident that we will be able to do so and look forward to sharing additional details on our progress throughout the year as we pursue these opportunities.”

https://seekingalpha.com/article/4416925-medicine-man-technologies-shwz-ceo-justin-dye-on-q4-2020-results-earnings-call-transcript